Cancer BiologybioRxivPreprint
Targeting Chromatin Effector Pygo2 to Enhance Immunotherapy in Prostate Cancer
Y. Zhu, Y. Zhao, J. Wen…·X. Lu
This study identifies Pygo2 as a driver oncogene in prostate cancer that suppresses immune infiltration and response to immunotherapy, showing that its inhibition enhances anti-tumor immunity.